Proceedings of the Expert Consensus Group meeting on meningococcal serogroup B disease burden and prevention in India

References

• World Health Organization. Report on Global Surveillance of Epidemic-prone Infectious Diseases. Chapter 5. Meningococcal Disease. [WHO/CDS/CSR/ISR/2000.2001]; [ accessed 2021 Mar 15]. https://www.who.int/csr/resources/publications/surveillance/Meningitis.pdf .
   Google Scholar
• Stephens DS. Biology and pathogenesis of the evolutionarily successful, obligate human bacterium Neisseria meningitidis. Vaccine. 2009;27(Suppl 2):B71–8. doi:10.1016/j.vaccine.2009.04.070.
   PubMed Web of Science ®Google Scholar
• Caugant DA, Brynildsrud OB. Neisseria meningitidis: using genomics to understand diversity, evolution and pathogenesis. Nat Rev Microbiol. 2020;18(2):84–96. doi:10.1038/s41579-019-0282-6.
   PubMed Web of Science ®Google Scholar
• Parikh SR, Campbell H, Bettinger JA, Harrison LH, Marshall HS, Martinon-Torres F, Safadi MA, Shao Z, Zhu B, von Gottberg A, et al. The everchanging epidemiology of meningococcal disease worldwide and the potential for prevention through vaccination. J Infect. 2020;81(4):483–98. doi:10.1016/j.jinf.2020.05.079.
   PubMed Web of Science ®Google Scholar
• Dutta AK, Swaminathan S, Abitbol V, Kolhapure S, Sathyanarayanan S. A comprehensive review of meningococcal disease burden in India. Infect Dis Ther. 2020;9(3):537–59. doi:10.1007/s40121-020-00323-4.
   PubMed Web of Science ®Google Scholar
• Sinclair D, Preziosi MP, Jacob John T, Greenwood B. The epidemiology of meningococcal disease in India. Trop Med Int Health. 2010;15(12):1421–35. doi:10.1111/j.1365-3156.2010.02660.x.
   PubMed Web of Science ®Google Scholar
• Thompson MJ, Ninis N, Perera R, Mayon-White R, Phillips C, Bailey L, Harnden A, Mant D, Levin M. Clinical recognition of meningococcal disease in children and adolescents. Lancet. 2006;367(9508):397–403. doi:10.1016/S0140-6736(06)67932-4.
   PubMed Web of Science ®Google Scholar
• Wang B, Santoreneos R, Giles L, Haji Ali Afzali H, Marshall H. Case fatality rates of invasive meningococcal disease by serogroup and age: A systematic review and meta-analysis. Vaccine. 2019;37(21):2768–82. doi:10.1016/j.vaccine.2019.04.020.
   PubMed Web of Science ®Google Scholar
• Centres for Disease Control and Prevention. Epidemiology and prevention of vaccine- preventable diseases. the Pink Book - Meningococcal Disease. [accessed 2021 Mar 15]. https://www.cdc.gov/vaccines/pubs/pinkbook/mening.html#:~:text=The%20case%2Dfatality%20ratio%20of,or%20loss%20of%20a%20limb
   Google Scholar
• Nair D, Dawar R, Deb M, Capoor MR, Singal S, Upadhayay DJ, Aggarwal P, Das B, Samantaray JC. Outbreak of meningococcal disease in and around New Delhi, India, 2005-2006: a report from a tertiary care hospital. Epidemiol Infect. 2009;137(4):570–76. doi:10.1017/S0950268808001398.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Meningococcal meningitis. [accessed 2021 Mar 15]. https://www.who.int/news-room/fact-sheets/detail/meningococcal-meningitis
   Google Scholar
• Pace D, Pollard AJ. Meningococcal disease: clinical presentation and sequelae. Vaccine. 2012;30(Suppl 2):B3–9. doi:10.1016/j.vaccine.2011.12.062.
   PubMed Web of Science ®Google Scholar
• Dass Hazarika R, Deka NM, Khyriem AB, Lyngdoh WV, Barman H, Duwarah SG, Jain P, Borthakur D. Invasive meningococcal infection: analysis of 110 cases from a tertiary care centre in North East India. Indian J Pediatr. 2013;80(5):359–64. doi:10.1007/s12098-012-0855-0.
   PubMed Web of Science ®Google Scholar
• Proulx N, Frechette D, Toye B, Chan J, Kravcik S. Delays in the administration of antibiotics are associated with mortality from adult acute bacterial meningitis. Qjm. 2005;98(4):291–98. doi:10.1093/qjmed/hci047.
   PubMed Web of Science ®Google Scholar
• Koster-Rasmussen R, Korshin A, Meyer CN. Antibiotic treatment delay and outcome in acute bacterial meningitis. J Infect. 2008;57(6):449–54. doi:10.1016/j.jinf.2008.09.033.
   PubMed Web of Science ®Google Scholar
• Smith I, Bjornevik AT, Augland IM, Berstad A, Wentzel-Larsen T, Halstensen A. Variations in case fatality and fatality risk factors of meningococcal disease in Western Norway, 1985-2002. Epidemiol Infect. 2006;134(1):103–10. doi:10.1017/S0950268805004553.
   PubMed Web of Science ®Google Scholar
• Villena R, Safadi MAP, Valenzuela MT, Torres JP, Finn A, Oʻ-Ryan M. Global epidemiology of serogroup B meningococcal disease and opportunities for prevention with novel recombinant protein vaccines. Hum Vaccin Immunother. 2018;14(5):1042–57. doi:10.1080/21645515.2018.1458175.
   PubMed Web of Science ®Google Scholar
• Caugant DA, Tzanakaki G, Kriz P. Lessons from meningococcal carriage studies. FEMS Microbiol Rev. 2007;31:52–63.
   PubMed Web of Science ®Google Scholar
• Trotter C, Maiden M. Chapter 2, Carriage and transmission of Neisseria meningitidis. In: Iea F, editor. Handbook of meningococcal disease management. Switzerland: Springer International Publishing Switzerland; 2016.
   Google Scholar
• Trotter CL, Gay NJ, Edmunds WJ. The natural history of meningococcal carriage and disease. Epidemiol Infect. 2006;134(3):556–66. doi:10.1017/S0950268805005339.
   PubMed Web of Science ®Google Scholar
• Yezli S, Assiri AM, Alhakeem RF, Turkistani AM, Alotaibi B. Meningococcal disease during the Hajj and Umrah mass gatherings. Int J Infect Dis. 2016;47:60–64. doi:10.1016/j.ijid.2016.04.007.
   PubMed Web of Science ®Google Scholar
• Yezli S, Wilder-Smith A, Bin Saeed AA. Carriage of Neisseria meningitidis in the Hajj and Umrah mass gatherings. Int J Infect Dis. 2016;47:65–70. doi:10.1016/j.ijid.2015.11.014.
   PubMed Web of Science ®Google Scholar
• Badahdah AM, Rashid H, Khatami A, Booy R. Meningococcal disease burden and transmission in crowded settings and mass gatherings other than Hajj/Umrah: A systematic review. Vaccine. 2018;36(31):4593–602. doi:10.1016/j.vaccine.2018.06.027.
   PubMed Web of Science ®Google Scholar
• Muttalif AR, Presa JV, Haridy H, Gamil A, Serra LC, Cane A. Incidence and prevention of invasive meningococcal disease in global mass gathering events. Infect Dis Ther. 2019;8(4):569–79. doi:10.1007/s40121-019-00262-9.
   PubMed Web of Science ®Google Scholar
• Dubey AP, Hazarika RD, Abitbol V, Kolhapure S, Agrawal S. Mass gatherings: a review of the scope for meningococcal vaccination in the Indian context. Hum Vaccin Immunother. 2021;17(7):2216–24. doi:10.1080/21645515.2020.1871572.
   PubMed Web of Science ®Google Scholar
• Office of the Registrar General & Census Commissioner, India. Ministry of Home Affairs, Government of India. Population density 2011 census data. [accessed 2021 Mar 18]. https://www.censusindia.gov.in/Census_Data_2001/India_at_Glance/density.aspx
   Google Scholar
• Spyromitrou-Xioufi P, Tsirigotaki M, Ladomenou F. Risk factors for meningococcal disease in children and adolescents: a systematic review and META-analysis. Eur J Pediatr. 2020;179(7):1017–27. doi:10.1007/s00431-020-03658-9.
   PubMed Web of Science ®Google Scholar
• Memish ZA, Zumla A, Alhakeem RF, Assiri A, Turkestani A, Al Harby KD, Alyemni M, Dhafar K, Gautret P, Barbeschi M et al.Hajj: infectious disease surveillance and control. Lancet. 2014;383(9934):2073–82. doi:10.1016/S0140-6736(14)60381-0.
   PubMed Web of Science ®Google Scholar
• Acevedo R, Bai X, Borrow R, Caugant DA, Carlos J, Ceyhan M, Christensen H, Climent Y, De Wals P, Dinleyici EC et al.The global meningococcal initiative meeting on prevention of meningococcal disease worldwide: epidemiology, surveillance, hypervirulent strains, antibiotic resistance and high-risk populations. Expert Rev Vaccines. 2019;18(1):15–30. doi:10.1080/14760584.2019.1557520.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Global Health International: India helps protect 150 million people at the worldʻs largest gathering. [accessed 2021 Mar 8]. https://www.cdc.gov/globalhealth/stories/kumbh-mela.html .
   Google Scholar
• Aye AMM, Bai X, Borrow R, Bory S, Carlos J, Caugant DA, Chiou CS, Dai VTT, Dinleyici EC, Ghimire P et al.Meningococcal disease surveillance in the Asia-Pacific region (2020): the global meningococcal initiative. J Infect. 2020;81(5):698–711. doi:10.1016/j.jinf.2020.07.025.
   PubMed Web of Science ®Google Scholar
• Sridhar S, Gautret P, Brouqui P. A comprehensive review of the Kumbh Mela: identifying risks for spread of infectious diseases. Clin Microbiol Infect. 2015;21(2):128–33. doi:10.1016/j.cmi.2014.11.021.
   PubMed Web of Science ®Google Scholar
• Khilnani GC, Tiwari P. Air pollution in India and related adverse respiratory health effects: past, present, and future directions. Curr Opin Pulm Med. 2018;24(2):108–16. doi:10.1097/MCP.0000000000000463.
   PubMed Web of Science ®Google Scholar
• Global Burden of Disease 2016 Risk Factors Collaborators. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;39010100:1345–422. doi:10.1016/S0140-6736(17)32366-8.
   PubMed Web of Science ®Google Scholar
• India State-Level Disease Burden Initiative Air Pollution Collaborators. The impact of air pollution on deaths, disease burden, and life expectancy across the states of India: the Global Burden of Disease Study 2017. Lancet Planet Health. 2019;31:e26–e39. doi:10.1016/S2542-5196(18)30261-4.
   PubMedGoogle Scholar
• Office of the Registrar General & Census Commissioner, India Ministry of Home Affairs, Government of India. Age structure and marital status. 2011 Census Data; [accessed 2021 Mar 19]. https://censusindia.gov.in/Census_And_You/age_structure_and_marital_status.aspx
   Google Scholar
• Caugant DA, Hoiby EA, Magnus P, Scheel O, Hoel T, Bjune G, Wedege E, Eng J, Froholm LO. Asymptomatic carriage of Neisseria meningitidis in a randomly sampled population. J Clin Microbiol. 1994;32(2):323–30. doi:10.1128/jcm.32.2.323-330.1994.
   PubMed Web of Science ®Google Scholar
• Christensen H, May M, Bowen L, Hickman M, Trotter CL. Meningococcal carriage by age: a systematic review and meta-analysis. Lancet Infect Dis. 2010;10(12):853–61. doi:10.1016/S1473-3099(10)70251-6.
   PubMed Web of Science ®Google Scholar
• Burman C, Serra L, Nuttens C, Presa J, Balmer P, York L. Meningococcal disease in adolescents and young adults: a review of the rationale for prevention through vaccination. Hum Vaccin Immunother. 2019;15(2):459–69. doi:10.1080/21645515.2018.1528831.
   PubMed Web of Science ®Google Scholar
• Jha D, Ghosh MK. Epidemiology of meningococcal carrier state amongst recruits of a military training centre. J Commun Dis. 1995;27:250–55.
   PubMedGoogle Scholar
• Bali NK, Mir H, Tantray VG, Ali S, Kakru DK, Koul PA. Meningococcal carriage among college freshmen in Kashmir, North India- A Single Centre Study. J Clin Diagn Res. 2017;11:13–17.
   Web of Science ®Google Scholar
• Gorthi SP, Nagpal AK. Meningococcal vaccine: which, when and for whom? Med J Armed Forces India. 2010;66(1):2–3. doi:10.1016/S0377-1237(10)80081-4.
   PubMedGoogle Scholar
• Bai X, Hu B, Yan Q, Luo T, Qu B, Jiang N, Liu J, Zhu Y. Effects of meteorological factors on the incidence of meningococcal meningitis. Afr Health Sci. 2017;17(3):820–26. doi:10.4314/ahs.v17i3.25.
   PubMed Web of Science ®Google Scholar
• Diseases under Surveillance - Integrated Disease Surveillance Programme (IDSP). National Centre for Disease Control, Directorate General of Health Services. Ministry of Health & Family Welfare, Goverment of India. [accessed 2021 Apr 24]. https://idsp.nic.in/index1.php?lang=1&level=1&sublinkid=5985&lid=3925
   Google Scholar
• John TJ, Gupta S, Chitkara AJ, Dutta AK, Borrow R. An overview of meningococcal disease in India: knowledge gaps and potential solutions. Vaccine. 2013;31(25):2731–37. doi:10.1016/j.vaccine.2013.04.003.
   PubMed Web of Science ®Google Scholar
• Integrated Disease Surveillance Programme (IDSP). National Centre for Disease Control, Directorate General of Health Services. Ministry of Health & Family Welfare, Goverment of India [MoHFW]. [accessed 2021 Mar 23]. https://idsp.nic.in/.
   Google Scholar
• Borrow R, Lee JS, Vazquez JA, Enwere G, Taha MK, Kamiya H, Kim HM, Jo DS, Global Meningococcal I. Meningococcal disease in the Asia-Pacific region: findings and recommendations from the global meningococcal initiative. Vaccine. 2016;34(48):5855–62. doi:10.1016/j.vaccine.2016.10.022.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Laboratory methods for the diagnosis of meningitis caused by Neisseria meningitidis, Streptococcus pneumoniae, and Haemophilus influenzae. Second edition (2011). [accessed 2021 Apr 24]. https://www.cdc.gov/meningitis/lab-manual/index.html .
   Google Scholar
• Van de Beek D, Cabellos C, Dzupova O, Esposito S, Klein M, Kloek AT, Leib SL, Mourvillier B, Ostergaard C, Pagliano P et al.ESCMID guideline: diagnosis and treatment of acute bacterial meningitis. Clin Microbiol Infect. 2016;22(Suppl 3):S37–62. doi:10.1016/j.cmi.2016.01.007.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Laboratory methods for the diagnosis of meningitis. Chapter 7: Identification and Characterization of Neisseria meningitidis. [accessed 2021 Apr 24]. https://www.cdc.gov/meningitis/lab-manual/chpt07-id-characterization-nm.html
   Google Scholar
• Moore JE. Meningococcal disease section 3: diagnosis and management: MeningoNI Forum (see page 87(2) 83 for full list of authors). Ulster Med J. 2018;87:94–98.
   PubMedGoogle Scholar
• McGettigan P, Roderick P, Kadam A, Pollock AM. Access, watch, and reserve antibiotics in India: challenges for WHO stewardship. Lancet Glob Health. 2017;5(11):e1075–e1076. doi:10.1016/S2214-109X(17)30365-0.
   PubMed Web of Science ®Google Scholar
• Klein EY, Van Boeckel TP, Martinez EM, Pant S, Gandra S, Levin SA, Goossens H, Laxminarayan R. Global increase and geographic convergence in antibiotic consumption between 2000 and 2015. Proc Natl Acad Sci U S A. 2018;115(15):E3463–E3470. doi:10.1073/pnas.1717295115.
   PubMed Web of Science ®Google Scholar
• Vyse A, Wolter JM, Chen J, Ng T, Soriano-Gabarro M. Meningococcal disease in Asia: an under-recognized public health burden. Epidemiol Infect. 2011;139(7):967–85. doi:10.1017/S0950268811000574.
   PubMed Web of Science ®Google Scholar
• Lucidarme J, Scott KJ, Ure R, Smith A, Lindsay D, Stenmark B, Jacobsson S, Fredlund H, Cameron JC, Smith-Palmer A et al.An international invasive meningococcal disease outbreak due to a novel and rapidly expanding serogroup W strain, Scotland and Sweden, July to August 2015. Euro Surveill. 2016;21(45):30395. doi:10.2807/1560-7917.ES.2016.21.45.30395.
   PubMedGoogle Scholar
• Aggarwal M, Manchanda V, Talukdar B. Meningitis due to Neisseria meningitidis serogroup B in India. Indian Pediatr. 2013;50:601–03.
   PubMed Web of Science ®Google Scholar
• Devi U, Mahanta J. Neonatal meningitis due to Neisseria meningitidis serogroup Y. Indian Pediatr. 2014;51:757.
   PubMed Web of Science ®Google Scholar
• World Population Prospects Highlights 2019. United Nations Department of Economic and Social Affairs ST/ESA/SER.A/2423. [accessed 2021 Apr 25]. https://population.un.org/wpp/Publications/Files/WPP2019_Highlights.pdf
   Google Scholar
• India State-Level Disease Burden Initiative Collaborators. Nations within a nation: variations in epidemiological transition across the states of India, 1990-2016 in the Global Burden of Disease Study. Lancet. 2017;39010111:2437–60. doi:10.1016/S0140-6736(17)32804-0.
   PubMed Web of Science ®Google Scholar
• Central Bureau of Health Intelligence. Directorate General of Health Services. Ministry of Health & Family Welfare, Goverment of India. 2019. National health profile 14th issue. [accessed 2021 Mar 24]. http://www.cbhidghs.nic.in/showfile.php?lid=1147
   Google Scholar
• World Health Organization. Immunization, Vaccines, and Biologicals. Meningococcal meningitis; [accessed 2021 Apr 26]. https://www.who.int/teams/immunization-vaccines-and-biologicals/diseases/meningitis
   Google Scholar
• Wyle FA, Artenstein MS, Brandt BL, Tramont EC, Kasper DL, Altieri PL, Berman SL, Lowenthal JP. Immunologic response of man to group B meningococcal polysaccharide vaccines. J Infect Dis. 1972;126(5):514–21. doi:10.1093/infdis/126.5.514.
   PubMed Web of Science ®Google Scholar
• Finne J, Leinonen M, Makela PH. Antigenic similarities between brain components and bacteria causing meningitis. Implications for vaccine development and pathogenesis. Lancet. 1983;322(8346):355–57. doi:10.1016/S0140-6736(83)90340-9.
   Google Scholar
• Andrews SM, Pollard AJ. A vaccine against serogroup B Neisseria meningitidis: dealing with uncertainty. Lancet Infect Dis. 2014;14(5):426–34. doi:10.1016/S1473-3099(13)70341-4.
   PubMed Web of Science ®Google Scholar
• Vipond C, Care R, Feavers IM. History of meningococcal vaccines and their serological correlates of protection. Vaccine. 2012;30(Suppl 2):B10–17. doi:10.1016/j.vaccine.2011.12.060.
   PubMed Web of Science ®Google Scholar
• Parikh SR, Andrews NJ, Beebeejaun K, Campbell H, Ribeiro S, Ward C, White JM, Borrow R, Ramsay ME, Ladhani SN. Effectiveness and impact of a reduced infant schedule of 4cmenb vaccine against group B meningococcal disease in England: a national observational cohort study. Lancet. 2016;388(10061):2775–82. doi:10.1016/S0140-6736(16)31921-3.
   PubMed Web of Science ®Google Scholar
• Marshall HS, Richmond PC, Beeslaar J, Jiang Q, Jansen KU, Garces-Sanchez M, Martinon-Torres F, Szenborn L, Wysocki J, Eiden J et al.Meningococcal serogroup B-specific responses after vaccination with bivalent rLP2086: 4 year follow-up of a randomised, single-blind, placebo-controlled, phase 2 trial. Lancet Infect Dis. 2017;17(1):58–67. doi:10.1016/S1473-3099(16)30314-0.
   PubMed Web of Science ®Google Scholar
• Deceuninck G, Lefebvre B, Tsang R, Betala-Belinga JF, De Serres G, De Wals P. Impact of a mass vaccination campaign against Serogroup B meningococcal disease in the Saguenay-Lac-Saint-Jean region of Quebec four years after its launch. Vaccine. 2019;37(31):4243–45. doi:10.1016/j.vaccine.2019.06.021.
   PubMed Web of Science ®Google Scholar
• Rivero-Calle I, Raguindin PF, Gomez-Rial J, Rodriguez-Tenreiro C, Martinon-Torres F. Meningococcal Group B Vaccine for the Prevention of Invasive Meningococcal Disease Caused by Neisseria meningitidis Serogroup B. Infect Drug Resist. 2019;12:3169–88. doi:10.2147/IDR.S159952.
   PubMed Web of Science ®Google Scholar
• Biolchi A, Tomei S, Brunelli B, Giuliani M, Bambini S, Borrow R, Claus H, Gorla MCO, Hong E, Lemos APS et al.4CMenB immunization induces serum bactericidal antibodies against Non-Serogroup B Meningococcal strains in adolescents. Infect Dis Ther. 2021;10(1):307–16. doi:10.1007/s40121-020-00370-x.
   PubMed Web of Science ®Google Scholar
• World Health Organization 2000 Report on Global Surveillance of Epidemic-prone Infectious Diseases - Meningococcal disease. [accessed 2021 Apr 26]. http://apps.who.int/iris/bitstream/handle/10665/66485/WHO_CDS_CSR_ISR_2000.1.pdf;jsessionid=2A5F9A2A1A2D9E89267717E1D6607807?sequence=1
   Google Scholar
• Halperin SA, Bettinger JA, Greenwood B, Harrison LH, Jelfs J, Ladhani SN, McIntyre P, Ramsay ME, Safadi MA. The changing and dynamic epidemiology of meningococcal disease. Vaccine. 2012;30(Suppl 2):B26–36. doi:10.1016/j.vaccine.2011.12.032.
   PubMed Web of Science ®Google Scholar
• Mohammed I, Iliyasu G, Habib AG. Emergence and control of epidemic meningococcal meningitis in sub-Saharan Africa. Pathog Glob Health. 2017;111(1):1–6. doi:10.1080/20477724.2016.1274068.
   PubMed Web of Science ®Google Scholar
• LaForce FM, Djingarey M, Viviani S, Preziosi MP. Successful African introduction of a new Group A meningococcal conjugate vaccine: Future challenges and next steps. Hum Vaccin Immunother. 2018;14(5):1098–102. doi:10.1080/21645515.2017.1378841.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Defeating meningitis 2030 : baseline situation analysis. [accessed 2021 Mar 15]. https://www.who.int/publications/m/item/defeating-meningitis-2030-baseline-situation-analysis
   Google Scholar
• Vaccine schedule. Meningococcal disease: recommended vaccinations. [accessed 2021 Dec 1]. https://vaccine-schedule.ecdc.europa.eu/Scheduler/ByDisease?SelectedDiseaseId=48%26SelectedCountryIdByDisease=-1
   Google Scholar
• NHS vaccinations and when to have them. [accessed 2021 Dec 6]. https://www.nhs.uk/conditions/vaccinations/nhs-vaccinations-and-when-to-have-them/.
   Google Scholar
• Table 1. Recommended child and adolescent immunization schedule for ages 18 years or younger, United States, 2021. [accessed 2021 Dec 6]. https://www.cdc.gov/vaccines/schedules/hcp/imz/child-adolescent.html#note-mening .
   Google Scholar
• Table 1. Recommended adult immunization schedule for ages 19 years or older, United States, 2021. [accessed 2021 Dec 6]. https://www.cdc.gov/vaccines/schedules/hcp/imz/adult.html#note-mening
   Google Scholar
• Taha M-K, Weil-Olivier C, Bouée S, Emery C, Nachbaur G, Pribil C, Loncle-Provot V. Risk factors for invasive meningococcal disease: a retrospective analysis of the French national public health insurance database. Hum Vaccin Immunother. 2021;17(6):1858–66. doi:10.1080/21645515.2020.1849518.
   PubMed Web of Science ®Google Scholar
• Petousis-Harris H, Paynter J, Morgan J, Saxton P, McArdle B, Goodyear-Smith F, Black S. Effectiveness of a group B outer membrane vesicle meningococcal vaccine against gonorrhoea in New Zealand: a retrospective case-control study. Lancet. 2017;390(10102):1603–10. doi:10.1016/S0140-6736(17)31449-6.
   PubMed Web of Science ®Google Scholar
• Harris SL, Tan C, Andrew L, Hao L, Liberator PA, Absalon J, Anderson AS, Jones TR. The bivalent factor H binding protein meningococcal serogroup B vaccine elicits bactericidal antibodies against representative non-serogroup B meningococci. Vaccine. 2018;36(45):6867–74. doi:10.1016/j.vaccine.2018.05.081.
   PubMed Web of Science ®Google Scholar
• Chen WH, Neuzil KM, Boyce CR, Pasetti MF, Reymann MK, Martellet L, Hosken N, LaForce FM, Dhere RM, Pisal SS et al.Safety and immunogenicity of a pentavalent meningococcal conjugate vaccine containing serogroups A, C, Y, W, and X in healthy adults: a phase 1, single-centre, double-blind, randomised, controlled study. Lancet Infect Dis. 2018;18(10):1088–96. doi:10.1016/S1473-3099(18)30400-6.
   PubMed Web of Science ®Google Scholar
• Pizza M, Bekkat-Berkani R, Rappuoli R. Vaccines against Meningococcal Diseases. Microorganisms. 2020;8(10):1521. doi:10.3390/microorganisms8101521.
   PubMed Web of Science ®Google Scholar
• National Health Portal India. Sexually transmitted infections (STIs). [accessed 2021 Apr 26]. https://www.nhp.gov.in/disease/reproductive-system/sexually-transmitted-infections-stis
   Google Scholar
• Sharma M, Rizvi M, Gupta R, Azam M, Khan HM, Parvez A, Shukla I. Alarming resistance of Neisseria gonorrhoeae in a tertiary care hospital of North India. Indian J Med Microbiol. 2018;36(2):285–88. doi:10.4103/ijmm.IJMM_18_123.
   PubMed Web of Science ®Google Scholar